Meet The Team
COG Nordics
2026 Partners
For more information on sponsorship opportunities, please contact Alex O’Leary.
Email: aol@thepbcgroup.com | Phone: +44 (0)7795 345 108.
Premium Partners
Aixial Group is more than a leading CRO - we are a strategic partner dedicated to driving your programme forward with confidence. We
deliver hands-on guidance, deep industry expertise, and a responsive, collaborative approach that ensures progress at every stage.
Aixial Group combines extensive therapeutic expertise in oncology, CNS, rare diseases, and radiopharmaceuticals with a global team
of more than 1,000 employees, to deliver adaptable CRO solutions, including full-service support, functional service provision, and consulting.
Everything we do is focused on what truly matters: achieving positive outcomes for our clients and their patients.
Aixial Group
Medidata is powering smarter treatments and healthier people through digital solutions to support clinical trials. With over 20 years of groundbreaking technological innovation across more than 30,000 trials and 9 million patients, Medidata offers industry-leading expertise, analytics-powered insights, and the largest patient-level historical clinical trial data set in the world. More than 1 million registered users across 2,100+ customers trust Medidata’s seamless, end-to-end platform to improve patient experiences, accelerate clinical breakthroughs, and bring therapies to market faster. A Dassault Systèmes company (Euronext Paris: FR0014003TT8, DSY.PA), Medidata is headquartered in New York City and has been recognized as a Leader by Everest Group and IDC.
Medidata
Thermo Fisher offers comprehensive clinical trial service capabilities including clinical supply optimization, clinical ancillaries, comparator sourcing, global clinical packaging and labeling, storage and clinical logistics, cold chain management, and decentralized trial offerings. With 30 cGMP-compliant sites and over 30+ years of experience advancing clinical trials, we have the resources and global network you need to support clinical trial success.
Thermo Fisher Scientific
TRI
At TRI, we lead the evolution of Risk-Based Quality Management.
We built OPRA to solve the challenges clinical teams face every day. It delivers what they need most: Trusted Processes, Responsive Oversight, and Innovative Solutions. OPRA brings Risk Management and Centralized Monitoring together in one powerful platform, helping teams achieve better outcomes and drive operational excellence.
We champion patient safety and compliance so every trial can succeed without compromise. RBQM forms the backbone of modern clinical research, and we are shaping its future today.
Exhibition Partners
CRScube is a global leader in eClinical solutions, dedicated to making clinical trials more accessible, efficient, and impactful. As Korea’s #1 eClinical vendor, CRScube’s cutting-edge technology streamlines clinical data capture and analysis while ensuring compliance with regulatory requirements worldwide. CRScube provides a cost-effective platform, trusted by over 1,000 clients and used in over 5,800 trials.
CRScube
As a trusted clinical data science partner with 35+ years of research-driven experience, IDDI combines therapeutic expertise, biostatistical leadership, and regulatory insight to mitigate risk by delivering uncompromising excellence in biostatistics, strategic consulting, and clinical data management. When every data point represents a patient, perfection is the only option.
IDDI
LINK Medical is a Nordic full-service CRO and regulatory consulting company providing services for drug development and medical device clients. With expertise across all trial phases, regulatory affairs, and market access, LINK Medical delivers efficient, high-quality solutions to accelerate innovation and improve patient outcomes globally.
Link Medical
.png)
METRONOMIA is your Data Science CRO for biostatistical services and consulting, clinical data management, and medical writing.
Since 1990, we have supported over 720 projects in all clinical development phases and major therapeutic areas.
Our team of 140+ highly skilled employees serves the needs of our pharma-, biotech-, and medical device customers with the highest degree of flexibility, reliability and quality.
METRONOMIA
Putting patients first is in uMotif’s DNA. The modern uMotif eCOA platform delivers faster, high-quality clinical trials and real-world studies by putting patients at the core of research. Combined with uMotif’s robust site tools – including consent management, site productivity, and trial awareness – the platform strengthens the patient-site relationship, which is key to improving eCOA compliance and retention. With cloud hosting in the US, Europe, and China, the GCP, 21 CFR Part 11 and GDPR-compliant platform supports all study phases and indications.
uMotif
Associate Partners
Fortrea
Fortrea is a leading global clinical research organization (CRO) with over 30 years of clinical research experience, providing comprehensive Phase I-IV trial management, clinical pharmacology, and consulting services across 20+ therapeutic areas. Evolved from Covance and Labcorp, Fortrea is built for biotech and biopharma, medical device and diagnostic innovators, delivering agile, fit-for-purpose full service (FSO), functional service (FSP) and hybrid solutions in about 100 countries. We combine scientific rigor and operational excellence with innovation to help bring therapies from pipeline to patient. Together, exceptional is possible.
.jpeg)
ICON
ICON is the world's leading clinical research organisation, powered by healthcare intelligence. From molecule to medicine, we advance clinical research providing outsourced development and commercialisation services to pharmaceutical, biotechnology, medical device and government and public health organisations. We develop new innovations, drive emerging therapies forward and improve patient lives.
Optimapharm
Optimapharm is a globally operating, leading, mid-sized, full-service CRO aiming to deliver new therapies to improve and save patients’ lives.
Whether a pharmaceutical, biotech, or medical device company, we are your ideal mid-sized, full-service CRO.
Our in-depth expertise and long-lasting experience, combined with a flexible and collaborative approach, allow us to tailor our responses to each individual study.
Our clinical development capabilities span trial Phases I-IV, across a broad range of therapeutic areas, including medical devices.
We have an excellent track record for supporting a range of stakeholders in the pharmaceutical industry, including sponsors and research institutions at each clinical development phase.
Precision for Medicine
Precision medicine is in our blood, our cells, our genes, and our name. Precision for Medicine, the full-service global CRO, is purpose-built to accelerate clinical research and development processes to bring life-changing therapeutics to those who need them most. We integrate clinical operations excellence, laboratory expertise, and advanced data sciences to deliver on the promise of personalized therapy; translating research into real-world results and forever reimaging how to get there.
Suvoda is a global clinical trial technology company specializing in highly complex, life-sustaining studies in therapeutic areas like oncology, CNS, and rare disease. Suvoda empowers clinical trial professionals to manage the most urgent moments in the most urgent trials through IRT, eConsent, and eCOA solutions delivered on a single platform.
Suvoda
.jpg)
Viedoc
At Viedoc, we design engaging software that modernizes clinical research so that necessary treatments can reach the people who need them faster. We accomplish this by combining technology and a creative design to streamline, automate and simplify conventional processes within clinical research. Viedoc makes every aspect of a clinical study a bit smoother, resulting in greater discoveries that make a difference and has the potential to improve lives.
Networking Partners
Media Partner
International Clinical Trials (ICT) is a specialist journal that discusses the various stages of clinical trials programmes, the funding behind them, and the trends that dictate their feasibility.
Published quarterly, the journal offers a platform of communication and information-sharing for executive and strategic decision makers, seeking out new trends and marketing opportunities, as well as putting a spotlight on the latest innovations coming to market. ICT is specifically designed to be of interest to those actively seeking to source services for improved efficiency in what is an increasingly competitive market.
Prompted by the synergies between trial operations and wider contract research and outsourcing issues, ICT joined forces with sister title European Pharmaceutical Contractor (EPC) in late-2015, in a move that brings added value to both brands. With EPC now an inserted edition within ICT, industry practitioners across these complementary subject areas now have unrivalled access to a wealth of shared views and analyses.
International Clinical Trials (ICT)
